Or use the contact form below:
[contact-form]

Or use the contact form below:
[contact-form]

BGG Invites you to visit us at the SSW Show, BOOTH 12093, Las Vegas, Oct 12-13, 2011

Info on the Show – Map to our Booth

BGG is a Multinational in the Nutraceuticals Industry. Its
Biotechnology Laboratory in Beijing is World-class and has accumulated
close to 20 years-worth of investment, growth and expertise employing some
of the foremost talent in the Industry.

This altogether results in BGG being differentiated because the Company
demonstrates its capabilities to deliver Market-leading Products, as
support by its published Data: BGG delivers unrivaled Purity and Quality:
hence BGG is known for ‘Authentic Extracts’.

September 1st, 2011

This reflects its steady expansion internationally – that has reached a
point where a broader identity is justified.

The new Web Address allows Home Page access to each of BGG’s Offices in
North America, China, Japan and Europe – already in the U.K., and the
Swiss Office is opening shortly. Russia also is to open but early 2012.

BGG is a Multinational in the Nutraceuticals Industry. Its
Biotechnology Laboratory in Beijing is World-class and has accumulated
close to 20 years-worth of investment, growth and expertise employing some
of the foremost talent in the Industry.

This altogether results in BGG being differentiated because the Company
demonstrates its capabilities to deliver Market-leading Products, as
support by its published Data: BGG delivers unrivaled Purity and Quality:
hence BGG is known for ‘Authentic Extracts’.

September 1st, 2011

We are proud to announce that we are changing company our name from Beijing Ginko Group to BGG.

The name change is due to the significant expansion of our business activities.

The name change should also be perceived as an acknowledgement of the size, strength, and diversity of the entire BGG Company – making “BGG” the cornerstone of our branding worldwide.

The company will continue to operate in its current structure and your contacts will remain un-changed. At the same time we will change all our e-mail to reflect the @bggworld domain to reflect and strengthen the BGG brand. The old e-mail addresses will continue to be operational for the foreseeable future.

BGG is a Multinational in the Nutraceuticals Industry. Its
Biotechnology Laboratory in Beijing is World-class and has accumulated
close to 20 years-worth of investment, growth and expertise employing some
of the foremost talent in the Industry.

This altogether results in BGG being differentiated because the Company
demonstrates its capabilities to deliver Market-leading Products, as
support by its published Data: BGG delivers unrivaled Purity and Quality:
hence BGG is known for ‘Authentic Extracts’.

September 1st, 2011

Chunhua Li, Chairman and CEO said ‘We are extremely pleased that our
Beijing-based Team of Research Chemists have researched and recommended
that our sourcing of these Extracts can be processed and made available to
the Market at a Quality and Purity Level that warrants our Stamp of
Approval as being labeled ‘Authentic Extracts’.

BGG is a Multinational in the Nutraceuticals Industry. Its
Biotechnology Laboratory in Beijing is World-class and has accumulated
close to 20 years-worth of investment, growth and expertise employing some
of the foremost talent in the Industry.

This altogether results in BGG being differentiated because the Company
demonstrates its capabilities to deliver Market-leading Products, as
support by its published Data: BGG delivers unrivaled Purity and Quality:
hence BGG is known for Authentic Extracts.

Julu 15th, 2011

A Presentation from Capsugel outlining their SEDDS and SMEDDS surfactant technology is available upon request. This technology, initially developed by Capsugel’s parent company, Pfizer, Inc., spontaneously emulsifies poorly soluble compounds for enhanced bioavailability.

Capsugel has applied this technology to ingredients such as CoQ10, Resveratrol, Astaxanthin, and Vitamin-E; and NOW to BGG’s ThinOgen™ and FucoMax™. (Fucoxanthin).

Chunhua Li, BGG’s Chairman and CEO, said today, “BGG is proud and pleased to be partnering with Capsugel, and their parent Pfizer, Inc., throughout these clinical studies, that are ground-breaking in their advancement of mankind’s knowledge and understanding of how to improve the efficacy of supplements, and their absorption in the human body, for maximum benefit to supporting the best of health…

…the application of SEDDS to CoQ10 in an animal study resulted in a 200% increase in bioavailability. Similarly, the application of  SEDDS to Vitamin-E in a human study resulted in a 200% increase in bioavailability.

BGG and Capsugel (Pfizer, Inc.) expect to see similar results with the application of SMEDDS to ThinOgen ™ and FucoMax™ (Fucoxanthin) in our upcoming clinical trial.

And BGG and Capsugel (Pfizer,Inc.) also are working in close co-operation to develop the next generation of a highly bioavailability Fucoxanthin product for optimal fat-loss performance“.

BGG is a privately held China-based Botanical Extract company, established over sixteen years ago. BGG is a World Leader in the production of European Bilberry Extract, Licorice Derivatives, Gingko Biloba Extract,
FucoMax ™, Fucoidan, and ThinOgen ™, Fucoxanthin (brown seaweed extracts), LingonMax ™, Lingonberry Extract, and many other ingredients for the Dietary Supplement, Food, Pharmaceutical, and Cosmetics Industries.

BGG now operates eight production facilities throughout China, and has over 400 employees. BGG’s core processing capabilities include aqueous and solvent extraction, vacuum concentration, molecular distillation, chromatographic column separation, and spray drying.

Production Quality Control ensures that BGG exceeds Compliance Standards and/with Certifications regulated and enforced by ISO, GMP, Kosher and Halal.

Efficiently located alongside BGG’s state-of-the-art Research and Development Headquarters in Changping, the entire plant has been designed to fully comply with, and exceed, GMP and other important global Standards.

Chunha Li, Chairman and CEO said today at the inauguration ceremony “This significant investment and commitment to our continuing growth will enable BGG to substantially increase production of Ginnovay™ European Bilberry Extract to 80 MT per year, as well as enable us to expand production of our broad product portfolio of other essential ingredients, such as ThinOgen ™ FucoMAX™“.

BGG is a privately held China-based Botanical Extract company, established over sixteen years ago. BGG is a World Leader in the production of European Bilberry Extract, Licorice Derivatives, Gingko Biloba Extract,
FucoMax ™, Fucoidan, and ThinOgen ™,  LingonMax ™, Lingonberry Extract, and many other ingredients for the Dietary Supplement, Food, Pharmaceutical, and Cosmetics Industries.

BGG now operates eight production facilities throughout China, and has over 400 employees. BGG’s core processing capabilities include aqueous and solvent extraction, vacuum concentration, molecular distillation, chromatographic column separation, and spray drying. Production Quality Control ensures that BGG exceeds Compliance Standards and/with Certifications regulated and enforced by ISO, GMP, Kosher and Halal.

According to company President Chunhua Li, “The new research supports our quality commitment in this exciting product category. It clearly confirms that ThinOgen™ Plus is incomparably effective in controlling body weight and fat control.” Complete findings of the study are available in a recently published White Paper, available upon request.

A proprietary blend of fucoxanthin and other ingredients, ThinOgen™ Plus was administered in a randomized clinical trial to 19 subjects for three months to measure and assess its weight and fat loss effects. Comprised of males and seven females ranging from 25 to 50 years old, the subjects were in the BMI range of 23.0 to 40.0 kg/m2 and free of severe metabolic disease demanding medical control, cancer, malnutrition, pregnancy or lactation and other anti-obesity products used within the prior three months). Control group subjects received a placebo, with the balance receiving various dosages of ThinOgen™ Plus.

After the first month, 92.7 percent of the 2mg/d group and 95 percent of the 4mg/d group reported weight and fat loss. After the second month, 93 percent of the 2mg/d group and 95 percent of the 4mg/d group reported loss. After the third month, 94.5 percent of the 2mg/d group and 99 percent of the 4mg/d group reported loss compared to the placebo group, with the highest reported weight loss rate at 9.21 percent. During the fourth month, supplementation was halted, but weight and fat loss continued for the 2mg/d and 4mg/d groups. Further, CT scans measured the subjects’ abdominal fat areas and determined a strong likelihood for continued fat loss.

ThinOgen™ Plus increases the production of UCP-1 proteins, allowing for more protons to pass through the UCP channels. This process diverts energy from ATP synthesis, which transforms substances such as sugar and fat to energy, to thermogenesis. Unlike traditional anti-obesity products that block fat absorption and generally leading to rapid weight regain following use, thermogenesis generated by fucoxanthin supplementation significantly delays weight regain.

Also unlike traditional products, ThinOgen™ Plus generated no side effects. Specifically, no test group participants reported digestive issues such as decreased appetite, nausea, vomiting or gastrointestinal discomfort. On the contrary, several subjects noted a decrease in constipation. There were no reports of increased thirst or urination, confirming the supplement’s non-diuretic characteristics. Dysphoria, agrypnia, restlessness, sweating and other issues often associated with amphetamines and fenfluramine were not present. Additionally, no subjects reported an increase in blood pressure or heart rate, palpitations, dizziness or other cardiovascular issues.

“ThinOgen™ Plus enabled slow and stable weight and fat loss for subjects with a BMI greater than 23.4,” “This is the safest way to lose weight and fat but also the key to keeping it off.”

“While BGG encourages healthy diet and regular exercise, the research proves ThinOgen™ Plus contributed to significant weight and fat loss without a regulated diet and exercise program. In effect, ThinOgen™ Plus surpasses other weight loss products currently on the market with higher potency and no side effects, and does it all at reduced costs.”

For additional information about ThinOgen™ Plus, contact the company at (949) 748-7348.